BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25875936)

  • 1. Diagnostic potential of zinc finger protein-specific autoantibodies and associated linear B-cell epitopes in colorectal cancer.
    O'Reilly JA; Fitzgerald J; Fitzgerald S; Kenny D; Kay EW; O'Kennedy R; Kijanka GS
    PLoS One; 2015; 10(4):e0123469. PubMed ID: 25875936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of the IgM and IgG Autoantibody Immune Responses in Human Serum has High Predictive Value for the Presence of Colorectal Cancer.
    Fitzgerald S; O'Reilly JA; Wilson E; Joyce A; Farrell R; Kenny D; Kay EW; Fitzgerald J; Byrne B; Kijanka GS; O'Kennedy R
    Clin Colorectal Cancer; 2019 Mar; 18(1):e53-e60. PubMed ID: 30366678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer.
    Fan CW; Kuo YB; Lin GP; Chen SM; Chang SH; Li BA; Chan EC
    Clin Chim Acta; 2017 Dec; 475():157-163. PubMed ID: 29074220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple serological biomarkers for colorectal cancer detection.
    Chan CC; Fan CW; Kuo YB; Chen YH; Chang PY; Chen KT; Hung RP; Chan EC
    Int J Cancer; 2010 Apr; 126(7):1683-90. PubMed ID: 19795454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
    Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
    Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
    Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
    Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Blood Autoantibodies in the Detection of Colorectal Cancer.
    Negm OH; Hamed MR; Schoen RE; Whelan RL; Steele RJ; Scholefield J; Dilnot EM; Shantha Kumara HM; Robertson JF; Sewell HF
    PLoS One; 2016; 11(7):e0156971. PubMed ID: 27383396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seromic profiling of colorectal cancer patients with novel glycopeptide microarray.
    Pedersen JW; Blixt O; Bennett EP; Tarp MA; Dar I; Mandel U; Poulsen SS; Pedersen AE; Rasmussen S; Jess P; Clausen H; Wandall HH
    Int J Cancer; 2011 Apr; 128(8):1860-71. PubMed ID: 21344374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
    Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
    Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-panel assay of serum autoantibodies in colorectal cancer.
    Ushigome M; Nabeya Y; Soda H; Takiguchi N; Kuwajima A; Tagawa M; Matsushita K; Koike J; Funahashi K; Shimada H
    Int J Clin Oncol; 2018 Oct; 23(5):917-923. PubMed ID: 29691673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of autoantibodies against Rabphilin-3A-like protein as a potential biomarker in patient's sera of colorectal cancer.
    Chen JS; Kuo YB; Chou YP; Chan CC; Fan CW; Chen KT; Huang YS; Chan EC
    Clin Chim Acta; 2011 Jul; 412(15-16):1417-22. PubMed ID: 21536019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of diagnostic ELISA-based tests for the detection of auto-antibodies against tumor antigens in human serum.
    Stefatić D; Riederer M; Balić M; Dandachi N; Stanzer S; Janesch B; Resel M; Ler D; Samonigg H; Bauernhofer T
    Bosn J Basic Med Sci; 2008 Aug; 8(3):245-50. PubMed ID: 18816257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases.
    Decker P; Briand JP; de Murcia G; Pero RW; Isenberg DA; Muller S
    Arthritis Rheum; 1998 May; 41(5):918-26. PubMed ID: 9588745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
    Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
    Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.
    Chen H; Werner S; Tao S; Zörnig I; Brenner H
    Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of anti-GRP78 antibodies in the serum of patients with colorectal carcinoma: a potential biomarker for early cancer detection.
    Raiter A; Vilkin A; Gingold R; Levi Z; Halpern M; Niv Y; Hardy B
    Int J Biol Markers; 2014 Dec; 29(4):e431-5. PubMed ID: 24803280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades.
    Dyachenko L; Havrysh K; Lytovchenko A; Dosenko I; Antoniuk S; Filonenko V; Kiyamova R
    Dis Markers; 2016; 2016():5128720. PubMed ID: 27847402
    [No Abstract]   [Full Text] [Related]  

  • 18. A reverse-ELISA for the detection of TRIM28/KAP1 serum autoantibodies in colorectal cancer patients.
    Hector S; Chen H; Kijanka G; Murray F; Prehn JH
    Acta Oncol; 2012 Mar; 51(3):394-6. PubMed ID: 22268577
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicenter study identified molecular blood-born protein signatures for Wilms Tumor.
    Schmitt J; Heisel S; Keller A; Leidinger P; Ludwig N; Habel N; Furtwängler R; Nourkami-Tutdibi N; Wegert J; Grundy P; Gessler M; Graf N; Lenhof HP; Meese E
    Int J Cancer; 2012 Aug; 131(3):673-82. PubMed ID: 21913182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against HSF1 and CCDC155 as Biomarkers of Early-Stage, High-Grade Serous Ovarian Cancer.
    Wilson AL; Moffitt LR; Duffield N; Rainczuk A; Jobling TW; Plebanski M; Stephens AN
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):183-192. PubMed ID: 29141850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.